| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before income tax expense | -9,648 | -10,560 | -10,596 | -10,021 |
| Net loss before equity in net loss of joint venture | - | - | -10,596 | - |
| Net loss | -9,648 | -10,560 | -10,596 | -10,021 |
| Net loss per share, basic | -6.28 | -10.26 | -16.7 | -1.05 |
| Net loss per share, diluted | -6.28 | -10.26 | -16.7 | -1.05 |
| Weighted-average common stock outstanding, basic | 1,513,178 | 1,014,783 | 626,644 | 9,370,136 |
| Weighted-average common stock outstanding, diluted | 1,513,178 | 1,014,783 | 626,644 | 9,370,136 |
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)